Journal of Postgraduate Medicine, Education and Research

Register      Login

VOLUME 56 , ISSUE 2 ( April-June, 2022 ) > List of Articles


Neurological Disorders, Corticosteroids, and Fracture Risk: Hiding in the Hindsight!

Amit Kapila, Aastha Takkar

Citation Information : Kapila A, Takkar A. Neurological Disorders, Corticosteroids, and Fracture Risk: Hiding in the Hindsight!. J Postgrad Med Edu Res 2022; 56 (2):61-62.

DOI: 10.5005/jp-journals-10028-1570

License: CC BY-NC 4.0

Published Online: 07-06-2022

Copyright Statement:  Copyright © 2022; The Author(s).


  1. Lukert BP, Raisz LG. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 1990;112(5): 352–364. DOI: 10.7326/0003-4819-112-5-352
  2. Canalis E. Clinical review 83: mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. J Clin Endocrinol Metab 1996;81(10):3441–3447. DOI: 10.1210/jcem.81.10.8855781
  3. Moghadam-Kia S, Werth VP. Prevention and treatment of systemic glucocorticoid side effects. Int J Dermatol 2010;49(3):239–248. DOI: 10.1111/j.1365-4632.2009.04322.x
  4. Naganathan V, Jones G, Nash P, et al. Vertebral fracture risk with long-term corticosteroid therapy: prevalence and relation to age, bone density, and corticosteroid use. Arch Intern Med 2000;160(19): 2917–2922. DOI: 10.1001/archinte.160.19.2917
  5. Lloyd ME, Spector TD, Howard R. Osteoporosis in neurological disorders. J Neurol Neurosurg Psychiatry 2000;68(5):543–547. DOI: 10.1136/jnnp.68.5.543
  6. Leonard H, Downs J, Jian L, et al. Valproate and risk of fracture in Rett syndrome. Arch Dis Child 2010;95(6):444–448. DOI: 10.1136/adc.2008.148932
  7. Grossman JM, Gordon R, Ranganath VK, et al. American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res 2010;62(11):1515–1526. DOI: 10.1002/acr.20295
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.